← Back to Search

Behavioral Intervention

ACT with RAGE-Control for Aggression

N/A
Waitlist Available
Research Sponsored by Gonzalez-Heydrich, Joseph, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and two weeks post treatment
Awards & highlights

Study Summary

The purpose of this study is to determine whether adding an interactive biofeedback video game to anger control cognitive behavioral therapy is an effective and feasible treatment.

Eligible Conditions
  • Aggression
  • Anger

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and two weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and two weeks post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
State Trait Anger Expression Inventory - Child and Adolescent
Secondary outcome measures
Disruptive Behavior Disorder Rating Scale (DBDRS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACT with RAGE-ControlExperimental Treatment1 Intervention
10 session manualized cognitive behavioral anger control therapy augmented with an interactive biofeedback videogame.
Group II: Anger Control TherapyActive Control1 Intervention
10 session manualized cognitive behavioral anger control therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACT with RAGE-Control
2010
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

Gonzalez-Heydrich, Joseph, M.D.Lead Sponsor
2 Previous Clinical Trials
26 Total Patients Enrolled
1 Trials studying Aggression
20 Patients Enrolled for Aggression
Joseph W Gonzalez-Heydrich, MDStudy DirectorBoston Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025